A pilot trial of pentoxifylline in nonalcoholic steatohepatitis.
作者： Leon A. Adams , Claudia O. Zein , Paul Angulo , Keith D. Lindor
DOI: 10.1111/J.1572-0241.2004.40064.X
关键词:
摘要: … Pentoxifylline inhibits TNFα production. We therefore conducted a 12-month pilot trial to assess the efficacy and safety of pentoxifylline (… with administration of pentoxifylline. Strategies to …
nature.com
elsevier.com
lww.com
sci-hub.se 参考文章(23)
C MATTEONI, Z YOUNOSSI, T GRAMLICH, N BOPARAI, Y LIU, A MCCULLOUGH, Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. ,vol. 116, pp. 1413- 1419 ,(1999) , 10.1016/S0016-5085(99)70506-8
Sylvie Delanian, Raphael Porcher, Saida Balla-Mekias, Jean-Louis Lefaix, Randomized, Placebo-Controlled Trial of Combined Pentoxifylline and Tocopherol for Regression of Superficial Radiation-Induced Fibrosis Journal of Clinical Oncology. ,vol. 21, pp. 2545- 2550 ,(2003) , 10.1200/JCO.2003.06.064
Cheng-Chung Fang, Chung-Jen Yen, Yung-Ming Chen, Ren-Shi Shyu, Tun-Jun Tsai, Po-Huang Lee, Bor-Shen Hsieh, Pentoxifylline inhibits human peritoneal mesothelial cell growth and collagen synthesis: Effects on TGF-β Kidney International. ,vol. 57, pp. 2626- 2633 ,(2000) , 10.1046/J.1523-1755.2000.00123.X
G. Allen Holloway, Jamal Hoballah, Gary R. Seabrook, Donald E. McMillan, William Wolf, Vincent Falanga, Roy M. Fujitani, Carlos Diaz, Glen Hunter, Joseph Jorizzo, Peter F. Lawrence, Bok Y Lee, James O Menzoian, Lawrence L. Tretbar, Systemic treatment of venous leg ulcers with high doses of pentoxifylline : efficacy in a randomized, placebo-controlled trial Wound Repair and Regeneration. ,vol. 7, pp. 208- 213 ,(1999) , 10.1046/J.1524-475X.1999.00208.X
S. Q. Yang, H. Z. Lin, M. D. Lane, M. Clemens, A. M. Diehl, Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis Proceedings of the National Academy of Sciences. ,vol. 94, pp. 2557- 2562 ,(1997) , 10.1073/PNAS.94.6.2557
Karen Sliwa, Angela Woodiwiss, Geoffrey Candy, Danelle Badenhorst, Carlos Libhaber, Gavin Norton, Daniel Skudicky, Pinhas Sareli, Effects of pentoxifylline on cytokine profiles and left ventricular performance in patients with decompensated congestive heart failure secondary to idiopathic dilated cardiomyopathy. American Journal of Cardiology. ,vol. 90, pp. 1118- 1122 ,(2002) , 10.1016/S0002-9149(02)02779-0
JP Warne, Tumour necrosis factor alpha: a key regulator of adipose tissue mass Journal of Endocrinology. ,vol. 177, pp. 351- 355 ,(2003) , 10.1677/JOE.0.1770351
Ian R. Wanless, John S. Lentz, Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. ,vol. 12, pp. 1106- 1110 ,(1990) , 10.1002/HEP.1840120505
Michael Charlton, Pavla Kasparova, Shiobhan Weston, Keith Lindor, Yaakov Maor-Kendler, Russell H Wiesner, Charles B Rosen, Kenneth P Batts, Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease Liver Transplantation. ,vol. 7, pp. 608- 614 ,(2001) , 10.1053/JLTS.2001.25453
C. Windmeier, A.M. Gressner, Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. General Pharmacology-the Vascular System. ,vol. 29, pp. 181- 196 ,(1997) , 10.1016/S0306-3623(96)00314-X